Literature DB >> 29980292

Acute kidney injury complicating nephrotic syndrome of minimal change disease.

Alain Meyrier1, Patrick Niaudet2.   

Abstract

Minimal change disease accounts for 70% to 90% of cases of nephrotic syndrome in children. It also causes nephrotic syndrome in adults, including patients older than age 60. Renal function is altered moderately in approximately 20% to 30% of patients because foot-process fusion impairs filtration of water and solutes. The glomerular filtration rate is reduced by approximately 20% to 30% and returns to baseline with remission of proteinuria. Over the past 50 years, a number of publications have reported cases of acute kidney injury occurring in approximately one-fifth to one-third of adult cases in the absence of prior or concomitant renal disease. Clinical attributes point to a male predominance, age >50, massive proteinuria, severe hypoalbuminemia, a background of hypertension and vascular lesions on kidney biopsy, along with ischemic tubular necrosis. Acute kidney injury may require dialysis for weeks or months until remission of proteinuria allows resolution of oliguria. In some cases, renal function does not recover. An effect of endothelin-1-induced vasoconstriction at the onset of proteinuria has been proposed to explain tubular cell ischemic necrosis. The main factors causing acute kidney injury in patients with minimal change disease are diuretic-induced hypovolemia and nephrotoxic agents. Acute kidney injury is uncommon in children in the absence of intercurrent complications. Infection, nephrotoxic medication, and steroid resistance represent the main risk factors. In all patients, the goal of supportive therapy is essentially to buy time until glucocorticoids obtain remission of proteinuria, which allows resolution of renal failure.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKI; adults; children; diuretics; endothelin-1; kidney biopsy; minimal-change nephrotic syndrome; nephrotoxic drugs

Mesh:

Year:  2018        PMID: 29980292     DOI: 10.1016/j.kint.2018.04.024

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

Review 1.  [Minimal change disease and focal segmental glomerulosclerosis].

Authors:  J Müller-Deile; H Schenk; M Schiffer
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

2.  Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome.

Authors:  Gabriel Stefan; Ruxandra Busuioc; Simona Stancu; Madalina Hoinoiu; Adrian Zugravu; Nicoleta Petre; Gabriel Mircescu
Journal:  Clin Exp Nephrol       Date:  2020-10-22       Impact factor: 2.801

3.  Nephrotic Syndrome Complications - New and Old. Part 2.

Authors:  Ruxandra Mihaela Busuioc; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-06

4.  Differences in Multicomponent Pharmacokinetics, Tissue Distribution, and Excretion of Tripterygium Glycosides Tablets in Normal and Adriamycin-Induced Nephrotic Syndrome Rat Models and Correlations With Efficacy and Hepatotoxicity.

Authors:  Wei Wu; Rui Cheng; Hamza Boucetta; Lei Xu; Jing-Ru Pan; Min Song; Yu-Ting Lu; Tai-Jun Hang
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

5.  Prediction model of renal function recovery for primary membranous nephropathy with acute kidney injury.

Authors:  Tianxin Chen; Ying Zhou; Jianfen Zhu; Xinxin Chen; Jingye Pan
Journal:  BMC Nephrol       Date:  2022-07-13       Impact factor: 2.585

6.  Factors predicting the recovery from acute kidney injury in children with primary nephrotic syndrome.

Authors:  Na Guan; Yong Yao; Huijie Xiao; Jie Ding; Xuhui Zhong; Fang Wang; Xiaoyu Liu; Hongwen Zhang; Baige Su
Journal:  Clin Exp Nephrol       Date:  2021-05-15       Impact factor: 2.801

7.  Low-Density Lipoprotein Apheresis in Patients with Acute Kidney Injury Due to Minimal Change Disease Requiring Acute Renal Replacement Therapy.

Authors:  Kohsuke Terada; Koji Mugishima; Sayuri Kawasaki; Fumiaki Itagaki; Takehisa Yamada; Yukinao Sakai
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-06-18

Review 8.  Mechanisms and management of edema in pediatric nephrotic syndrome.

Authors:  Mahmoud Kallash; John D Mahan
Journal:  Pediatr Nephrol       Date:  2020-11-20       Impact factor: 3.714

9.  Lower albumin level and longer disease duration are risk factors of acute kidney injury in hospitalized children with nephrotic syndrome.

Authors:  Eun Mi Yang; Kee Hwan Yoo; Yo Han Ahn; Seong Heon Kim; Jung Won Lee; Woo Yeong Chung; Min Hyun Cho; Kee Hyuck Kim; Heeyeon Cho; Mee Jeong Lee; Jin-Soon Suh; Hye Sun Hyun; Jiwon M Lee; Myung Hyun Cho; Ji Hyun Kim; Il-Soo Ha; Hae Il Cheong; Hee Gyung Kang
Journal:  Pediatr Nephrol       Date:  2020-09-05       Impact factor: 3.714

10.  Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome.

Authors:  Tianxin Chen; Ying Zhou; Xinxin Chen; Bo Chen; Jingye Pan
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.